midomafetamine (MDMA) / Multidisciplinary Association for Psychedelic Studies (MAPS) 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 


«1234»
  • ||||||||||  midomafetamine (MDMA) / Multidisciplinary Association for Psychedelic Studies (MAPS)
    Trial initiation date:  RBRAIN-MDMA: Stanford Regulating Circuits of the Brain Study - MDMA (clinicaltrials.gov) -  Mar 9, 2020   
    P=N/A,  N=40, Not yet recruiting, 
    Initiation date: Jan 2020 --> Jun 2020
  • ||||||||||  midomafetamine (MDMA) / Multidisciplinary Association for Psychedelic Studies (MAPS)
    Enrollment open:  MDMA in Subjects With Moderate Hepatic Impairment and Subjects With Normal Hepatic Function (clinicaltrials.gov) -  Feb 19, 2020   
    P1,  N=16, Recruiting, 
    Trial completion date: Feb 2020 --> May 2020 | Trial primary completion date: Jan 2020 --> May 2020 Not yet recruiting --> Recruiting
  • ||||||||||  midomafetamine (MDMA) / Multidisciplinary Association for Psychedelic Studies (MAPS)
    Trial completion date, Trial primary completion date:  Evaluation of MDMA on Startle Response (clinicaltrials.gov) -  Feb 19, 2020   
    P1,  N=30, Recruiting, 
    Active, not recruiting --> Completed Trial completion date: Dec 2019 --> Jul 2020 | Trial primary completion date: Nov 2019 --> Jul 2020
  • ||||||||||  midomafetamine (MDMA) / Multidisciplinary Association for Psychedelic Studies (MAPS)
    Trial completion:  Study of Safety and Effects of MDMA-assisted Psychotherapy for Treatment of PTSD (Canada) (clinicaltrials.gov) -  Feb 19, 2020   
    P2,  N=4, Completed, 
    Trial completion date: Dec 2019 --> Jul 2020 | Trial primary completion date: Nov 2019 --> Jul 2020 Active, not recruiting --> Completed
  • ||||||||||  midomafetamine (MDMA) / Multidisciplinary Association for Psychedelic Studies (MAPS)
    Trial completion date, Trial primary completion date:  MDMA in Subjects With Moderate Hepatic Impairment and Subjects With Normal Hepatic Function (clinicaltrials.gov) -  Oct 17, 2019   
    P1,  N=16, Not yet recruiting, 
    Trial completion date: Apr 2020 --> Jul 2020 Trial completion date: Jan 2020 --> Apr 2020 | Trial primary completion date: Dec 2019 --> Mar 2020
  • ||||||||||  Trial completion date, Trial primary completion date:  Psychological Effects of Methylenedioxymethamphetamine (MDMA) When Administered to Healthy Volunteers (clinicaltrials.gov) -  Oct 17, 2019   
    P1,  N=100, Enrolling by invitation, 
    Trial completion date: Jan 2020 --> Apr 2020 | Trial primary completion date: Dec 2019 --> Mar 2020 Trial completion date: Sep 2019 --> Feb 2020 | Trial primary completion date: Aug 2019 --> Jan 2020
  • ||||||||||  midomafetamine (MDMA) / Multidisciplinary Association for Psychedelic Studies (MAPS)
    Trial completion date, Trial primary completion date:  Evaluation of MDMA on Startle Response (clinicaltrials.gov) -  Aug 14, 2019   
    P1,  N=30, Recruiting, 
    N=400 --> 150 Trial completion date: Aug 2019 --> Dec 2019 | Trial primary completion date: Jul 2019 --> Nov 2019
  • ||||||||||  midomafetamine (MDMA) / Multidisciplinary Association for Psychedelic Studies (MAPS)
    Trial completion date, Trial primary completion date:  Study of Safety and Effects of MDMA-assisted Psychotherapy for Treatment of PTSD (Canada) (clinicaltrials.gov) -  Jul 23, 2019   
    P2,  N=5, Active, not recruiting, 
    Trial completion date: Aug 2019 --> Dec 2019 | Trial primary completion date: Jul 2019 --> Nov 2019 Trial completion date: Jul 2019 --> Oct 2019 | Trial primary completion date: Jun 2019 --> Sep 2019
  • ||||||||||  midomafetamine (MDMA) / Multidisciplinary Association for Psychedelic Studies (MAPS)
    Trial completion date, Trial primary completion date:  A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP1) (clinicaltrials.gov) -  Jun 4, 2019   
    P3,  N=100, Recruiting, 
    Trial completion date: Jul 2019 --> Oct 2019 | Trial primary completion date: Jun 2019 --> Sep 2019 Trial completion date: Dec 2019 --> Jun 2020 | Trial primary completion date: Nov 2019 --> Jun 2020
  • ||||||||||  Trial completion date, Trial primary completion date:  Psychological Effects of Methylenedioxymethamphetamine (MDMA) When Administered to Healthy Volunteers (clinicaltrials.gov) -  May 3, 2019   
    P1,  N=120, Enrolling by invitation, 
    Trial completion date: Dec 2019 --> Jun 2020 | Trial primary completion date: Nov 2019 --> Jun 2020 Trial completion date: Apr 2019 --> Sep 2019 | Trial primary completion date: Mar 2019 --> Aug 2019
  • ||||||||||  midomafetamine (MDMA) / Multidisciplinary Association for Psychedelic Studies (MAPS)
    Trial initiation date:  MDMA in Subjects With Moderate Hepatic Impairment and Subjects With Normal Hepatic Function (clinicaltrials.gov) -  May 3, 2019   
    P1,  N=16, Not yet recruiting, 
    Trial completion date: Apr 2019 --> Sep 2019 | Trial primary completion date: Mar 2019 --> Aug 2019 Initiation date: Mar 2019 --> Jun 2019
  • ||||||||||  midomafetamine (MDMA) / Multidisciplinary Association for Psychedelic Studies (MAPS)
    Enrollment closed:  Study of Safety and Effects of MDMA-assisted Psychotherapy for Treatment of PTSD (Canada) (clinicaltrials.gov) -  Feb 21, 2019   
    P2,  N=5, Active, not recruiting, 
    Recruiting --> Active, not recruiting | N=60 --> 38 Recruiting --> Active, not recruiting
  • ||||||||||  midomafetamine (MDMA) / Multidisciplinary Association for Psychedelic Studies (MAPS)
    Trial completion date, Trial primary completion date:  Open Label Multi-Site Study of Safety and Effects of MDMA-assisted Therapy for Treatment of PTSD (clinicaltrials.gov) -  Feb 20, 2019   
    P2,  N=60, Recruiting, 
    Recruiting --> Active, not recruiting Trial completion date: May 2019 --> Aug 2019 | Trial primary completion date: Mar 2019 --> Jul 2019
  • ||||||||||  midomafetamine (MDMA) / Multidisciplinary Association for Psychedelic Studies (MAPS)
    Trial completion date, Trial primary completion date:  Open Label Multi-Site Study of Safety and Effects of MDMA-assisted Therapy for Treatment of PTSD (clinicaltrials.gov) -  Jan 14, 2019   
    P2,  N=60, Recruiting, 
    Trial completion date: May 2019 --> Aug 2019 | Trial primary completion date: Mar 2019 --> Jul 2019 Trial completion date: Jan 2019 --> May 2019 | Trial primary completion date: Dec 2018 --> Mar 2019
  • ||||||||||  midomafetamine (MDMA) / Multidisciplinary Association for Psychedelic Studies (MAPS)
    Trial completion date, Trial initiation date, Trial primary completion date:  MDMA in Subjects With Moderate Hepatic Impairment and Subjects With Normal Hepatic Function (clinicaltrials.gov) -  Dec 12, 2018   
    P1,  N=16, Not yet recruiting, 
    Trial completion date: Jan 2019 --> May 2019 | Trial primary completion date: Dec 2018 --> Mar 2019 Trial completion date: Sep 2019 --> Dec 2019 | Initiation date: Nov 2018 --> Mar 2019 | Trial primary completion date: Aug 2019 --> Nov 2019
  • ||||||||||  midomafetamine (MDMA) / Multidisciplinary Association for Psychedelic Studies (MAPS)
    Trial completion date, Trial primary completion date:  Evaluation of MDMA on Startle Response (clinicaltrials.gov) -  Dec 11, 2018   
    P1,  N=30, Recruiting, 
    Trial completion date: Sep 2019 --> Dec 2019 | Initiation date: Nov 2018 --> Mar 2019 | Trial primary completion date: Aug 2019 --> Nov 2019 Trial completion date: Jan 2019 --> Apr 2019 | Trial primary completion date: Nov 2018 --> Mar 2019
  • ||||||||||  Trial completion date, Trial primary completion date:  Psychological Effects of Methylenedioxymethamphetamine (MDMA) When Administered to Healthy Volunteers (clinicaltrials.gov) -  Dec 5, 2018   
    P1,  N=100, Enrolling by invitation, 
    Trial completion date: Jan 2019 --> Apr 2019 | Trial primary completion date: Nov 2018 --> Mar 2019 Trial completion date: Dec 2018 --> Apr 2019 | Trial primary completion date: Oct 2018 --> Mar 2019
  • ||||||||||  midomafetamine (MDMA) / Multidisciplinary Association for Psychedelic Studies (MAPS)
    Enrollment open:  A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP1) (clinicaltrials.gov) -  Nov 7, 2018   
    P3,  N=100, Recruiting, 
    Trial completion date: Dec 2018 --> Apr 2019 | Trial primary completion date: Oct 2018 --> Mar 2019 Not yet recruiting --> Recruiting
  • ||||||||||  midomafetamine (MDMA) / Multidisciplinary Association for Psychedelic Studies (MAPS)
    Trial completion date:  A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP1) (clinicaltrials.gov) -  Nov 2, 2018   
    P3,  N=100, Not yet recruiting, 
    Not yet recruiting --> Recruiting Trial completion date: Aug 2019 --> Dec 2019
  • ||||||||||  midomafetamine (MDMA) / Multidisciplinary Association for Psychedelic Studies (MAPS)
    Trial completion date, Trial primary completion date:  Evaluation of MDMA on Startle Response (clinicaltrials.gov) -  Sep 13, 2018   
    P1,  N=30, Recruiting, 
    Trial completion date: Aug 2019 --> Dec 2019 Trial completion date: Sep 2018 --> Jan 2019 | Trial primary completion date: Aug 2018 --> Nov 2018
  • ||||||||||  midomafetamine (MDMA) / Multidisciplinary Association for Psychedelic Studies (MAPS)
    Trial completion:  MDMA-Assisted Psychotherapy for Anxiety Associated With a Life-Threatening Illness (clinicaltrials.gov) -  Jul 13, 2018   
    P2,  N=18, Completed, 
    Trial primary completion date: Jun 2018 --> Oct 2018 Active, not recruiting --> Completed
  • ||||||||||  midomafetamine (MDMA) / Multidisciplinary Association for Psychedelic Studies (MAPS)
    Trial completion date, Trial primary completion date:  MDMA-Assisted Cognitive-Behavioral Conjoint Therapy (CBCT) in Dyads in Which 1 Member Has Chronic PTSD (clinicaltrials.gov) -  Feb 26, 2018   
    P1/2,  N=12, Active, not recruiting, 
    Active, not recruiting --> Completed Trial primary completion date: Jan 2018 --> May 2018 | Trial completion date: Mar 2018 --> Jul 2018
  • ||||||||||  midomafetamine (MDMA) / Multidisciplinary Association for Psychedelic Studies (MAPS)
    Trial primary completion date:  MDMA-Assisted Psychotherapy for Anxiety Associated With a Life-Threatening Illness (clinicaltrials.gov) -  Dec 8, 2017   
    P2,  N=18, Active, not recruiting, 
    Trial primary completion date: Jan 2018 --> May 2018 | Trial completion date: Mar 2018 --> Jul 2018 Trial primary completion date: Oct 2017 --> May 2018
  • ||||||||||  midomafetamine (MDMA) / Multidisciplinary Association for Psychedelic Studies (MAPS)
    Enrollment closed, Enrollment change, Trial primary completion date:  MDMA-Assisted Cognitive-Behavioral Conjoint Therapy (CBCT) in Dyads in Which 1 Member Has Chronic PTSD (clinicaltrials.gov) -  Oct 18, 2017   
    P1/2,  N=12, Active, not recruiting, 
    Active, not recruiting --> Completed Recruiting --> Active, not recruiting | N=20 --> 12 | Trial primary completion date: Sep 2017 --> Jan 2018
  • ||||||||||  midomafetamine (MDMA) / Multidisciplinary Association for Psychedelic Studies (MAPS)
    Enrollment open:  Evaluation of MDMA on Startle Response (clinicaltrials.gov) -  Sep 25, 2017   
    P1,  N=30, Recruiting, 
    Recruiting --> Active, not recruiting | N=20 --> 12 | Trial primary completion date: Sep 2017 --> Jan 2018 Not yet recruiting --> Recruiting
  • ||||||||||  midomafetamine (MDMA) / Multidisciplinary Association for Psychedelic Studies (MAPS)
    New P1 trial:  Evaluation of MDMA on Startle Response (clinicaltrials.gov) -  Jun 8, 2017   
    P1,  N=30, Not yet recruiting,